Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Glaucoma Medications Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Glaucoma Medications Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Prostaglandin Analogs
      • 1.3.3 Beta Blockers
      • 1.3.4 Alpha Agonists
      • 1.3.5 Carbonic Anhydrase Inhibitors
      • 1.3.6 Combined Medications
    • 1.4 Market Segment by Application
      • 1.4.1 Global Glaucoma Medications Market Share by Application (2019-2025)
      • 1.4.2 Open-angle Glaucoma
      • 1.4.3 Closed-angle Glaucoma
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Glaucoma Medications Market Size
      • 2.1.1 Global Glaucoma Medications Revenue 2014-2025
      • 2.1.2 Global Glaucoma Medications Sales 2014-2025
    • 2.2 Glaucoma Medications Growth Rate by Regions
      • 2.2.1 Global Glaucoma Medications Sales by Regions 2014-2019
      • 2.2.2 Global Glaucoma Medications Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Glaucoma Medications Sales by Manufacturers
      • 3.1.1 Glaucoma Medications Sales by Manufacturers 2014-2019
      • 3.1.2 Glaucoma Medications Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Glaucoma Medications Revenue by Manufacturers (2014-2019)
      • 3.2.2 Glaucoma Medications Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Glaucoma Medications Market Concentration Ratio (CR5 and HHI)
    • 3.3 Glaucoma Medications Price by Manufacturers
    • 3.4 Key Manufacturers Glaucoma Medications Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Glaucoma Medications Market
    • 3.6 Key Manufacturers Glaucoma Medications Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Prostaglandin Analogs Sales and Revenue (2014-2019)
      • 4.1.2 Beta Blockers Sales and Revenue (2014-2019)
      • 4.1.3 Alpha Agonists Sales and Revenue (2014-2019)
      • 4.1.4 Carbonic Anhydrase Inhibitors Sales and Revenue (2014-2019)
      • 4.1.5 Combined Medications Sales and Revenue (2014-2019)
    • 4.2 Global Glaucoma Medications Sales Market Share by Type
    • 4.3 Global Glaucoma Medications Revenue Market Share by Type
    • 4.4 Glaucoma Medications Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Glaucoma Medications Sales by Application

    6 United States

    • 6.1 United States Glaucoma Medications Breakdown Data by Company
    • 6.2 United States Glaucoma Medications Breakdown Data by Type
    • 6.3 United States Glaucoma Medications Breakdown Data by Application

    7 European Union

    • 7.1 European Union Glaucoma Medications Breakdown Data by Company
    • 7.2 European Union Glaucoma Medications Breakdown Data by Type
    • 7.3 European Union Glaucoma Medications Breakdown Data by Application

    8 China

    • 8.1 China Glaucoma Medications Breakdown Data by Company
    • 8.2 China Glaucoma Medications Breakdown Data by Type
    • 8.3 China Glaucoma Medications Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Glaucoma Medications Breakdown Data by Company
    • 9.2 Rest of World Glaucoma Medications Breakdown Data by Type
    • 9.3 Rest of World Glaucoma Medications Breakdown Data by Application
    • 9.4 Rest of World Glaucoma Medications Breakdown Data by Countries
      • 9.4.1 Rest of World Glaucoma Medications Sales by Countries
      • 9.4.2 Rest of World Glaucoma Medications Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Pfizer
      • 10.1.1 Pfizer Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Glaucoma Medications
      • 10.1.4 Glaucoma Medications Product Introduction
      • 10.1.5 Pfizer Recent Development
    • 10.2 Novartis
      • 10.2.1 Novartis Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Glaucoma Medications
      • 10.2.4 Glaucoma Medications Product Introduction
      • 10.2.5 Novartis Recent Development
    • 10.3 bausch Lomb
      • 10.3.1 bausch Lomb Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Glaucoma Medications
      • 10.3.4 Glaucoma Medications Product Introduction
      • 10.3.5 bausch Lomb Recent Development
    • 10.4 Laboratoire Riva
      • 10.4.1 Laboratoire Riva Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Glaucoma Medications
      • 10.4.4 Glaucoma Medications Product Introduction
      • 10.4.5 Laboratoire Riva Recent Development
    • 10.5 Jamp Pharma
      • 10.5.1 Jamp Pharma Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Glaucoma Medications
      • 10.5.4 Glaucoma Medications Product Introduction
      • 10.5.5 Jamp Pharma Recent Development
    • 10.6 Fresenius
      • 10.6.1 Fresenius Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Glaucoma Medications
      • 10.6.4 Glaucoma Medications Product Introduction
      • 10.6.5 Fresenius Recent Development
    • 10.7 Teva Pharmaceutical?
      • 10.7.1 Teva Pharmaceutical? Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Glaucoma Medications
      • 10.7.4 Glaucoma Medications Product Introduction
      • 10.7.5 Teva Pharmaceutical? Recent Development
    • 10.8 SANDOZ
      • 10.8.1 SANDOZ Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Glaucoma Medications
      • 10.8.4 Glaucoma Medications Product Introduction
      • 10.8.5 SANDOZ Recent Development
    • 10.9 Greenstone
      • 10.9.1 Greenstone Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Glaucoma Medications
      • 10.9.4 Glaucoma Medications Product Introduction
      • 10.9.5 Greenstone Recent Development
    • 10.10 Mylan
      • 10.10.1 Mylan Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Glaucoma Medications
      • 10.10.4 Glaucoma Medications Product Introduction
      • 10.10.5 Mylan Recent Development
    • 10.11 GE Medical
    • 10.12 Mint Pharmaceuticals
    • 10.13 Laboratoires Thea
    • 10.14 Taj Pharmaceuticals
    • 10.15 Actavis
    • 10.16 APOTEX
    • 10.17 Sun Pharma

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Glaucoma Medications Sales Channels
      • 11.2.2 Glaucoma Medications Distributors
    • 11.3 Glaucoma Medications Customers

    12 Market Forecast

    • 12.1 Global Glaucoma Medications Sales and Revenue Forecast 2019-2025
    • 12.2 Global Glaucoma Medications Sales Forecast by Type
    • 12.3 Global Glaucoma Medications Sales Forecast by Application
    • 12.4 Glaucoma Medications Forecast by Regions
      • 12.4.1 Global Glaucoma Medications Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Glaucoma Medications Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Glaucoma Medications is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Glaucoma Medications.

      This report studies the global market size of Glaucoma Medications, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Glaucoma Medications sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Pfizer
      Novartis
      bausch Lomb
      Laboratoire Riva
      Jamp Pharma
      Fresenius
      Teva Pharmaceutical?
      SANDOZ
      Greenstone
      Mylan
      GE Medical
      Mint Pharmaceuticals
      Laboratoires Thea
      Taj Pharmaceuticals
      Actavis
      APOTEX
      Sun Pharma

      Market Segment by Product Type
      Prostaglandin Analogs
      Beta Blockers
      Alpha Agonists
      Carbonic Anhydrase Inhibitors
      Combined Medications

      Market Segment by Application
      Open-angle Glaucoma
      Closed-angle Glaucoma

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Glaucoma Medications status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Glaucoma Medications manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Glaucoma Medications are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now